Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)
Argentina · Delayed Price · Currency is ARS 1,990.00
+10.00 (0.51%)
Feb 10, 2026, 4:49 PM BRT
BCBA:RICH Income Statement
Financials in millions ARS. Fiscal year is January - December.
Millions ARS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 103,496 | 91,794 | 84,989 | 57,518 | 32,366 | 9,330 | |
Revenue Growth (YoY) | 1.59% | 8.01% | 47.76% | 77.71% | 246.90% | 75.95% |
Cost of Revenue | 40,148 | 41,558 | 40,233 | 30,340 | 22,765 | 4,783 |
Gross Profit | 63,347 | 50,237 | 44,757 | 27,178 | 9,602 | 4,547 |
Selling, General & Admin | 38,409 | 32,973 | 33,217 | 17,935 | 5,110 | 2,218 |
Other Operating Expenses | 2,955 | 1,698 | - | - | - | - |
Operating Expenses | 41,363 | 34,671 | 33,217 | 17,935 | 5,110 | 2,218 |
Operating Income | 21,984 | 15,565 | 11,539 | 9,243 | 4,492 | 2,329 |
Interest Expense | -7,839 | -3,288 | -18,718 | -4,456 | -1,451 | -506.18 |
Interest & Investment Income | 7,203 | 7,203 | - | - | - | - |
Earnings From Equity Investments | -381.49 | -381.49 | -8.39 | 7.33 | - | - |
Currency Exchange Gain (Loss) | -10,886 | -8,731 | -55,069 | -9,159 | -1,783 | -881.81 |
Other Non Operating Income (Expenses) | 4,261 | 20,613 | 32,447 | 5,828 | 61.01 | 213.93 |
EBT Excluding Unusual Items | 14,342 | 30,982 | -29,808 | 1,462 | 1,319 | 1,154 |
Impairment of Goodwill | -1,828 | -1,828 | -523.72 | - | - | - |
Gain (Loss) on Sale of Investments | -18,128 | - | 10.26 | 1,019 | 1,436 | -11.36 |
Gain (Loss) on Sale of Assets | - | - | - | 8.19 | 6.46 | 0.58 |
Legal Settlements | -709.48 | -574.38 | - | - | - | - |
Pretax Income | -6,324 | 28,579 | -30,321 | 2,490 | 2,761 | 1,144 |
Income Tax Expense | -541.94 | 4,768 | -6,528 | 1,993 | 1,590 | 410.18 |
Earnings From Continuing Operations | -5,782 | 23,811 | -23,794 | 496.36 | 1,172 | 733.5 |
Minority Interest in Earnings | 107.79 | 33.7 | 164.53 | 12.58 | -19.42 | 0.44 |
Net Income | -5,674 | 23,845 | -23,629 | 508.94 | 1,152 | 733.94 |
Net Income to Common | -5,674 | 23,845 | -23,629 | 508.94 | 1,152 | 733.94 |
Net Income Growth | - | - | - | -55.83% | 56.98% | 362.98% |
Shares Outstanding (Basic) | 81 | 81 | 81 | 81 | 81 | 81 |
Shares Outstanding (Diluted) | 81 | 81 | 81 | 81 | 81 | 81 |
Shares Change (YoY) | 0.00% | 0.00% | -0.04% | 0.06% | -0.00% | -0.17% |
EPS (Basic) | -70.27 | 295.29 | -292.62 | 6.30 | 14.27 | 9.09 |
EPS (Diluted) | -70.27 | 295.29 | -292.62 | 6.30 | 14.27 | 9.09 |
EPS Growth | - | - | - | -55.85% | 56.99% | 363.78% |
Free Cash Flow | -29,356 | 897.9 | -25,022 | -34,174 | -3,045 | -742.76 |
Free Cash Flow Per Share | -363.53 | 11.12 | -309.87 | -423.02 | -37.71 | -9.20 |
Dividend Per Share | 26.890 | 26.890 | - | - | - | 0.555 |
Gross Margin | 61.21% | 54.73% | 52.66% | 47.25% | 29.67% | 48.73% |
Operating Margin | 21.24% | 16.96% | 13.58% | 16.07% | 13.88% | 24.96% |
Profit Margin | -5.48% | 25.98% | -27.80% | 0.89% | 3.56% | 7.87% |
Free Cash Flow Margin | -28.36% | 0.98% | -29.44% | -59.41% | -9.41% | -7.96% |
EBITDA | 24,218 | 20,077 | 17,533 | 11,522 | 5,165 | 2,584 |
EBITDA Margin | 23.40% | 21.87% | 20.63% | 20.03% | 15.96% | 27.69% |
D&A For EBITDA | 2,234 | 4,512 | 5,994 | 2,279 | 673.2 | 255.12 |
EBIT | 21,984 | 15,565 | 11,539 | 9,243 | 4,492 | 2,329 |
EBIT Margin | 21.24% | 16.96% | 13.58% | 16.07% | 13.88% | 24.96% |
Effective Tax Rate | - | 16.68% | - | 80.06% | 57.57% | 35.87% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.